Cargando…

SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease

The semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1) or primary amine oxidase (PrAO), is a deaminating enzyme highly expressed in vessels that generates harmful products as a result of its enzymatic activity. As a multifunctional enzyme, it is also invo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unzeta, Mercedes, Hernàndez-Guillamon, Mar, Sun, Ping, Solé, Montse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036996/ https://www.ncbi.nlm.nih.gov/pubmed/33805974 http://dx.doi.org/10.3390/ijms22073365

Ejemplares similares

Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases
por: Li, Hui, et al.
Publicado: (2021)

Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration
por: Schilter, Heidi C, et al.
Publicado: (2015)

Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO
por: Papukashvili, Dimitri, et al.
Publicado: (2020)

Endothelial cell-derived SSAO can increase MLC(20) phosphorylation in VSMCs
por: Zhang, Yuxing, et al.
Publicado: (2021)

Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study
por: Marazuela, Paula, et al.
Publicado: (2022)

Application of VAP bundles resulting in low incidence of VAP in ICU
por: Khan, FM, et al.
Publicado: (2011)

Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells
por: Manasieva, Vesna, et al.
Publicado: (2022)

Making Contact: VAP Targeting by Intracellular Pathogens
por: Murray, Rebecca, et al.
Publicado: (2018)

Correction: Papukashvili et al. “Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO” Nutrients, 2020, 12, 184
por: Papukashvili, Dimitri, et al.
Publicado: (2020)

The Biological Implication of Semicarbazide-Sensitive Amine Oxidase (SSAO) Upregulation in Rat Systemic Inflammatory Response under Simulated Aerospace Environment
por: Yan, Liben, et al.
Publicado: (2023)

Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study
por: Póvoa, Pedro, et al.
Publicado: (2016)

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
por: Unzeta, Mercedes, et al.
Publicado: (2016)

Use of a ventilator-associated pneumonia (VAP) bundle to decrease the VAP rate in Syria
por: Alsadat, R, et al.
Publicado: (2012)

Regulation of Enteric vapBC Transcription: Induction by VapC Toxin Dimer-Breaking
por: Winther, Kristoffer S., et al.
Publicado: (2012)

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
por: Di Bonito, Marianna, et al.
Publicado: (2012)

ClinVAP: a reporting strategy from variants to therapeutic options
por: Sürün, Bilge, et al.
Publicado: (2020)

Current place of probiotics for VAP
por: Virk, Harjeet Singh, et al.
Publicado: (2019)

ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
por: Marco-Contelles, José, et al.
Publicado: (2016)

The Nuclear Receptor PPARγ as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease
por: Nicolakakis, Nektaria, et al.
Publicado: (2010)

Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders
por: Ashayeri Ahmadabad, Rezan, et al.
Publicado: (2021)

Neurovascular crosstalk and cerebrovascular alterations: an underestimated therapeutic target in autism spectrum disorders
por: Wang, Yiran, et al.
Publicado: (2023)

What the VAP: The Expanded VAP Family of Proteins Interacting With FFAT and FFAT-Related Motifs for Interorganellar Contact
por: Neefjes, Jacques, et al.
Publicado: (2021)

Pericytes in Cerebrovascular Diseases: An Emerging Therapeutic Target
por: Su, Xiaojuan, et al.
Publicado: (2019)

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases
por: Liberale, Luca, et al.
Publicado: (2021)

Cerebrovascular disease and stroke
por: Pappachan, J, et al.
Publicado: (2008)

Death by acid rain: VAP or EXIT?
por: Thorburn, Kentigern, et al.
Publicado: (2009)

The Interactome of the VAP Family of Proteins: An Overview
por: James, Christina, et al.
Publicado: (2021)

Toxin-antitoxin loci vapBC-1 and vapXD contribute to survival and virulence in nontypeable Haemophilus influenzae
por: Ren, Dabin, et al.
Publicado: (2012)

The vapB–vapC Operon of Acidovorax citrulli Functions as a Bona-fide Toxin–Antitoxin Module
por: Shavit, Reut, et al.
Publicado: (2016)

Comparison of Morbidity, Mortality, and Costs of VAP Patients with Non-VAP Patients in the Tertiary Referral Hospital of Kerman, Iran
por: Ahmadipour, Maryam, et al.
Publicado: (2023)

VapC Toxins from Mycobacterium tuberculosis Are Ribonucleases that Differentially Inhibit Growth and Are Neutralized by Cognate VapB Antitoxins
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2011)

VapC from the Leptospiral VapBC Toxin-Antitoxin Module Displays Ribonuclease Activity on the Initiator tRNA
por: Lopes, Alexandre P. Y., et al.
Publicado: (2014)

Two venom allergen‐like proteins, HaVAP1 and HaVAP2, are involved in the parasitism of Heterodera avenae
por: Luo, Shujie, et al.
Publicado: (2019)

Cerebrovascular Disorders
por: Granata, Alessandra, et al.
Publicado: (2023)

How to approach and treat VAP in ICU patients
por: Borgatta, Bárbara, et al.
Publicado: (2014)

Only the new beginning of VAP quality control
por: Ding, Xin, et al.
Publicado: (2023)

Redefining Success for VAP: 360-Degree Approach
por: Nicolau, David P., et al.
Publicado: (2009)

Proteasomal-Mediated Degradation of AKAP150 Accompanies AMPAR Endocytosis during cLTD
por: Cheng, Wenwen, et al.
Publicado: (2020)

VapC21 Toxin Contributes to Drug-Tolerance and Interacts With Non-cognate VapB32 Antitoxin in Mycobacterium tuberculosis
por: Sharma, Arun, et al.
Publicado: (2020)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j18q3fd31v90rlrppkfngnlpq7